Disruptive Bio Trading ApS: Financial statements 2023
CVR: 41532580
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Disruptive Bio Trading ApS (CVR 41532580) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 31,874,153 and a net result of DKK 323,519 compared with DKK 7,973,563 the year before. That is a decrease of 68.1% compared with the year before. The profit margin was 1%. Equity in the 2023 report amounted to DKK 1,097,827. The solvency ratio was 14.3%. The company had 4 employees in the financial year.
- Revenue
- DKK 31,874,153
- Gross Profit
- DKK 4,004,189
- Profit/Loss
- DKK 323,519
- Equity
- DKK 1,097,827
- Total Assets
- DKK 7,693,821
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 31.9 mio. | 4 mio. | 324 t. | 1.1 mio. | 4 |
| 2022 | 100 mio. | 14.9 mio. | 8 mio. | 8.8 mio. | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Disruptive Bio Trading ApS has published its annual report for 2022. Revenue came to DKK 100,000,312, and the net result was DKK 7,973,563.
About Disruptive Bio Trading ApS
Disruptive Bio Trading ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2020. The company is registered under the industry Ikke-specialiseret engroshandel. The management consists of Nicki Sol Leander Soto. The company is owned by Lily Holding ApS and E.C. Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 7,990,769 and a net result of DKK 3,813,993 compared with DKK 1,498,942 the year before. Equity in the 2025 report amounted to DKK 4,085,762.